assessing the interaction between blood nfl levels and btk inhibitor efficacy in ms
Published 2 years ago • 97 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
4:22
btk inhibitors in treating the spectrum of ms
-
1:46
potential of btk inhibitors in ms
-
2:22
btk inhibitors for multiple sclerosis: progressive disease and de-escalation
-
4:39
stephen l. hauser, md: fenebrutinib and btk inhibiton in progressive ms
-
3:31
the potential of btkis in multiple sclerosis
-
52:31
rationale, evidence, and practical potential for btk inhibitors in patient-centered ms care
-
4:21
moving towards precision medicine in ms with snfl
-
21:30
btk inhibitors and multiple sclerosis
-
22:04
bruton's tyrosine kinase inhibitors for multiple sclerosis explained by neurologist
-
24:10
evaluating therapeutic trials
-
2:23
novel b-cell targeting approaches in ms
-
3:57
the molecular basis of ebv triggering multiple sclerosis
-
7:29
chapter 3 : the impact of stroke
-
4:20
blood and tissue tmb in predicting response to immunotherapy
-
26:33
pag 2020 series - dr. michael hiller
-
5:58
the availability of multiple biosimilars for 1 biologic
-
43:13
how to use biocompatibility to evaluate changes in a medical device
-
4:43
preliminary data on the use of sv2a as a biomarker of neurodegeneration in alzheimer’s disease